Hutchison China MediTech (HCM) Reports Q2 EPS of $0.03

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Hutchison China MediTech (HCM) Reports Q2 EPS of $0.03

Chi-Med Reports 2017 Interim Results and Updates Shareholders on Key Clinical Programs

July 31, 2017 2:00 AM EDT

LONDON--(BUSINESS WIRE)-- Hutchison China MediTech Limited (Chi-Med) (AIM/Nasdaq: HCM), the China-based biopharmaceutical company focused on discovering and developing targeted therapies for oncology and immunological diseases for the global market, today announces its unaudited financial results for the six months ended June 30, 2017.

Group: Record revenue; continued investment in clinical pipeline

Group revenue up 21% to $126.6 million (H1 2016: $104.5m). Net income attributable to Chi-Med of $1.7 million (H1 2016: $0.5m), including $37.5 million in research and development expenses on an as adjusted basis (H1 2016: $36.0m).... More